Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000572773 | SCV000663485 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000679360 | SCV000806210 | likely benign | not provided | 2017-04-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001086835 | SCV001006215 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000679360 | SCV001811028 | likely benign | not provided | 2018-07-12 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000572773 | SCV002530313 | likely benign | Hereditary cancer-predisposing syndrome | 2021-10-07 | criteria provided, single submitter | curation | |
Ce |
RCV000679360 | SCV004185425 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | PMS2: BP4, BP7 |
Color Diagnostics, |
RCV000572773 | SCV004358957 | likely benign | Hereditary cancer-predisposing syndrome | 2022-08-29 | criteria provided, single submitter | clinical testing |